美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Biofrontera Inc Warrant

0.0400

-0.0120-23.08%

成交量：2,787.00

成交額：134.95

市值：42.67萬

市盈率：-0.02

高：0.0520

開：0.0520

低：0.0400

收：0.0520

52周最高：0.2770

52周最低：0.0251

股本：1,066.84萬

流通股本：1,066.84萬

量比：9.14

換手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-1.8444

淨資產收益率：-325.31%

總資產收益率：-35.18%

市淨率：0.02

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Biofrontera Inc宣佈兩項臨牀研究數據庫鎖定，助力關鍵數據與監管里程碑達成

Biofrontera Inc. 完成 Ameluz® 和 Rhodoled® 的 FDA 批准轉移及相關知識產權組合的轉讓

Biofrontera Inc. 宣佈將 Xepi® 抗生素乳膏的許可出售給 Pelthos Therapeutics Inc.，最高可達 1000 萬美元

Biofrontera Inc宣佈Ameluz®(鹽酸氨基酮戊酸)外用凝膠10%光動力療法治療四肢、頸部和軀幹光化性角化病三期研究最後一名患者完成試驗

Biofrontera Inc宣佈Ameluz®（鹽酸氨基乙酰丙酸）10%外用凝膠治療中重度尋常痤瘡的2B期研究完成最後一名患者出組

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BFRIW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BFRIW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BFRIW\",,,,,undefined,":{"symbol":"BFRIW","market":"US","secType":"STK","nameCN":"Biofrontera Inc Warrant","latestPrice":0.04,"timestamp":1769115600000,"preClose":0.052,"halted":0,"volume":2787,"delay":0,"changeRate":-0.23076923076923073,"floatShares":10668438,"shares":10668438,"eps":-1.8444,"marketStatus":"盤前交易","change":-0.012,"latestTime":"01-23 09:04:10 EST","open":0.052,"high":0.052,"low":0.04,"amount":134.9483,"amplitude":0.230769,"askPrice":0.065,"askSize":100,"bidPrice":0.037,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.8444,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1769178600000},"marketStatusCode":1,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":0.04,"volumeRatio":9.137708213599684},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BFRIW\",,,,,undefined,":{"symbol":"BFRIW","floatShares":10668438,"roa":"-35.18%","roe":"-325.31%","lyrEps":0,"volumeRatio":9.137708213599684,"shares":10668438,"dividePrice":0,"high":0.052,"amplitude":0.230769,"preClose":0.052,"low":0.04,"week52Low":0.0251,"pbRate":"0.02","psRate":"0.02","week52High":0.277,"institutionHeld":0,"latestPrice":0.04,"eps":-1.8444,"divideRate":0,"volume":2787,"delay":0,"ttmEps":-1.8444,"open":0.052,"prevYearClose":0.09,"prevWeekClose":0.0513,"prevMonthClose":0.09,"prevQuarterClose":0.09,"fiveDayClose":0.0613,"twentyDayClose":0.07,"sixtyDayClose":0.0971},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BFRIW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BFRIW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BFRIW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BFRIW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141539493","title":"Biofrontera Inc宣佈兩項臨牀研究數據庫鎖定，助力關鍵數據與監管里程碑達成","url":"https://stock-news.laohu8.com/highlight/detail?id=1141539493","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141539493?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 21:50","pubTimestamp":1767880249,"startTime":"0","endTime":"0","summary":"Biofrontera Inc宣布，其两项临床研究已完成数据库锁定，此举将为关键数据的获取及后续监管里程碑的实现提供重要支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRIW","BK4007","BFRI"],"gpt_icon":0},{"id":"1137380408","title":"Biofrontera Inc. 完成 Ameluz® 和 Rhodoled® 的 FDA 批准轉移及相關知識產權組合的轉讓","url":"https://stock-news.laohu8.com/highlight/detail?id=1137380408","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137380408?lang=zh_tw&edition=fundamental","pubTime":"2025-12-18 21:50","pubTimestamp":1766065819,"startTime":"0","endTime":"0","summary":"Biofrontera Inc. 完成 Ameluz® 和 Rhodoled® 的 FDA 批准转移及相关知识产权组合的转让","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI","BK4007","BFRIW"],"gpt_icon":0},{"id":"1160367010","title":"Biofrontera Inc. 宣佈將 Xepi® 抗生素乳膏的許可出售給 Pelthos Therapeutics Inc.，最高可達 1000 萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160367010","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160367010?lang=zh_tw&edition=fundamental","pubTime":"2025-11-07 21:02","pubTimestamp":1762520543,"startTime":"0","endTime":"0","summary":"Biofrontera Inc. 宣布将 Xepi® 抗生素乳膏的许可出售给 Pelthos Therapeutics Inc.，最高可达 1000 万美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BFRIW","BFRI"],"gpt_icon":0},{"id":"1185650039","title":"Biofrontera Inc宣佈Ameluz®(鹽酸氨基酮戊酸)外用凝膠10%光動力療法治療四肢、頸部和軀幹光化性角化病三期研究最後一名患者完成試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1185650039","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185650039?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 22:30","pubTimestamp":1758033054,"startTime":"0","endTime":"0","summary":"Biofrontera Inc近日宣布，其针对Ameluz®(盐酸氨基酮戊酸)外用凝胶10%光动力疗法的三期临床研究已完成最后一名患者的试验。该研究旨在评估这种光动力疗法治疗四肢、颈部和躯干部位光化性角化病的有效性和安全性。\n随着最后一名受试者完成研究流程，这项重要的三期临床试验正式结束患者招募和治疗阶段。这标志着Biofrontera Inc在推进其Ameluz®产品用于治疗特定部位光化性角化病方面取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BFRIW","BFRI"],"gpt_icon":0},{"id":"1182774938","title":"Biofrontera Inc宣佈Ameluz®（鹽酸氨基乙酰丙酸）10%外用凝膠治療中重度尋常痤瘡的2B期研究完成最後一名患者出組","url":"https://stock-news.laohu8.com/highlight/detail?id=1182774938","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182774938?lang=zh_tw&edition=fundamental","pubTime":"2025-08-25 20:25","pubTimestamp":1756124753,"startTime":"0","endTime":"0","summary":"Biofrontera Inc宣布Ameluz®（盐酸氨基乙酰丙酸）10%外用凝胶治疗中重度寻常痤疮的2B期研究完成最后一名患者出组","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BFRIW","BFRI"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}